quinazolines has been researched along with Neglected Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behera, R; Edwards, P; Guyett, PJ; Karver, CE; Mensa-Wilmot, K; Patel, G; Pollastri, MP; Roncal, NE; Sullenberger, C | 1 |
| Barber, MM; Manetsch, R; Van Horn, KS; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X | 1 |
| Choudhary, MI; Ghouri, N; Khan, KM; Perveen, S; Saad, SM | 1 |
3 other study(ies) available for quinazolines and Neglected Diseases
| Article | Year |
|---|---|
Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Coloring Agents; Drug Design; Drug Discovery; ErbB Receptors; Humans; Indicators and Reagents; Lapatinib; Morpholines; Neglected Diseases; Phosphotransferases; Quinazolines; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2013 |
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Antiprotozoal Agents; Diamines; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Neglected Diseases; Quinazolines; Structure-Activity Relationship | 2015 |
4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Humans; Leishmania major; Leishmaniasis; Molecular Structure; Neglected Diseases; Parasitic Sensitivity Tests; Quinazolines; Structure-Activity Relationship | 2016 |